01521

2.0800.48%
JW

Jingsong Wang

Founder, Chairman & CEO

Dr. Jingsong Wang M.D., Ph.D., is Independent Non-Executive Director of InSilico Medicine Cayman TopCo from June 2023. Dr. Wang serves as Chairman of Board of Directors of HBM Alpha Therapeutics, Inc. He has been Chief Executive Officer of HBM Holdings Limited and Harbour BioMed Shanghai Co., Ltd. since December 2016. Dr. Wang serves as the Chairman of the Board at HBM Holdings Limited and also Founder of HBM Holdings Limited. Dr. Wang has been Executive Director of HBM Holdings Limited since July 20, 2016. From November 2011 to December 2015, he was the Head of China R&D of Sanofi (China) Investment Co., Ltd. Dr. Wang serves as the Independent Non-executive Director at Frontage Holdings Corporation since April 17, 2018. Dr. Wang was a medical physician and surgeon in Pennsylvania, United States. Dr. Wang has published in numerous leading scientific journals related to inflammation, autoimmune diseases and translational medicine. Dr. Wang serves on the board of directors of Silicon Therapeutics LLC, a Boston based biotech company focusing on the design of novel small molecule therapeutics in highly unmet disease areas since August 2016. Dr. Wang received his M.D. in clinical medicine from Xuzhou Medical College in China in June 1986, his master’s degree in medical science (immunology) from Jilin University (formerly known as Norman Bethune University of Medical Science before the combination with Jilin University) in China in July 1989 and his Ph.D. in molecular pharmacology from China Pharmaceutical University in China in July 2011.

Positions